Abirateron, Darreichungsform: TAB (ATC-Code: L02BX03)

TENDER DESCRIPTION

This announcement serves the conclusion of agreements for the active ingredient "Abiraterone, dosage form: TAB (ATC code: L02BX03)" with pharmaceutical companies within the meaning of § 130a para. 8 sentence 1 Social Code, Book Five (SGB V) (discount agreements). According to § 130a para. 8 sentence 1 SGB V, the invitation to participate is addressed only to pharmaceutical entrepreneurs or employee groups of pharmaceutical entrepreneurs within the meaning of § 4 para. 18 Medicines Act (AMG). This is not an open procedure, but a publication of the invitation to conclude/join discount agreements with fixed and non-negotiable conditions for all participants, including the amount of the discount. The corresponding information under section 2.1 "Type of procedure" and under section 5.1.12 "Condition for award_here: period for which the offer must be valid" are only due to the systematics of this form. Contractual partners can be an unlimited number of pharmaceutical entrepreneurs or employee groups of pharmaceutical entrepreneurs within the meaning of § 4 para. 18 Medicines Act (AMG). The contract conclusion or joining takes place by submitting the required completed self-declarations…

TENDER BRIEF

TENDER DOCUMENTS